EP2010213A4 - Uses and compositions for treatment of juvenile rheumatoid arthritis - Google Patents
Uses and compositions for treatment of juvenile rheumatoid arthritisInfo
- Publication number
- EP2010213A4 EP2010213A4 EP07755184A EP07755184A EP2010213A4 EP 2010213 A4 EP2010213 A4 EP 2010213A4 EP 07755184 A EP07755184 A EP 07755184A EP 07755184 A EP07755184 A EP 07755184A EP 2010213 A4 EP2010213 A4 EP 2010213A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- treatment
- rheumatoid arthritis
- juvenile rheumatoid
- juvenile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13172516.0A EP2666479A3 (en) | 2006-04-10 | 2007-04-10 | Uses and compositions for treatment of juvenile rheumatoid arthritis |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79090906P | 2006-04-10 | 2006-04-10 | |
US80977006P | 2006-05-30 | 2006-05-30 | |
US81548906P | 2006-06-20 | 2006-06-20 | |
US85837606P | 2006-11-10 | 2006-11-10 | |
PCT/US2007/008826 WO2007120651A2 (en) | 2006-04-10 | 2007-04-10 | Uses and compositions for treatment of juvenile rheumatoid arthritis |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13172516.0A Division EP2666479A3 (en) | 2006-04-10 | 2007-04-10 | Uses and compositions for treatment of juvenile rheumatoid arthritis |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2010213A2 EP2010213A2 (en) | 2009-01-07 |
EP2010213A4 true EP2010213A4 (en) | 2010-08-11 |
Family
ID=38610129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07755184A Withdrawn EP2010213A4 (en) | 2006-04-10 | 2007-04-10 | Uses and compositions for treatment of juvenile rheumatoid arthritis |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2010213A4 (en) |
WO (1) | WO2007120651A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2010011955A (en) | 2008-04-29 | 2011-01-21 | Abbott Lab | Dual variable domain immunoglobulins and uses thereof. |
MX2010013239A (en) * | 2008-06-03 | 2011-02-24 | Abbott Lab | Dual variable domain immunoglobulins and uses thereof. |
NZ589436A (en) | 2008-06-03 | 2012-12-21 | Abbott Lab | Dual variable domain immunoglobulins and uses thereof |
CN102149825B (en) | 2008-07-08 | 2015-07-22 | Abbvie公司 | Prostaglandin E2 dual variable domain immunoglobulins and uses thereof |
JP2013507928A (en) | 2009-10-15 | 2013-03-07 | アボット・ラボラトリーズ | Dual variable domain immunoglobulins and uses thereof |
UY32979A (en) | 2009-10-28 | 2011-02-28 | Abbott Lab | IMMUNOGLOBULINS WITH DUAL VARIABLE DOMAIN AND USES OF THE SAME |
WO2012018790A2 (en) | 2010-08-03 | 2012-02-09 | Abbott Laboratories | Dual variable domain immunoglobulins and uses thereof |
CN103260639A (en) | 2010-08-26 | 2013-08-21 | Abbvie公司 | Dual variable domain immunoglobulins and uses thereof |
BR112014015851A2 (en) | 2011-12-30 | 2019-09-24 | Abbvie Inc | double specific binding proteins directed against il-13 and / or il-17 |
KR20210111353A (en) | 2012-11-01 | 2021-09-10 | 애브비 인코포레이티드 | Anti-vegf/dll4 dual variable domain immunoglobulins and uses thereof |
MX2015013166A (en) | 2013-03-15 | 2015-12-11 | Abbvie Inc | Dual specific binding proteins directed against il-1 beta and il-17. |
WO2016094881A2 (en) | 2014-12-11 | 2016-06-16 | Abbvie Inc. | Lrp-8 binding proteins |
TW201710286A (en) | 2015-06-15 | 2017-03-16 | 艾伯維有限公司 | Binding proteins against VEGF, PDGF, and/or their receptors |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002012502A2 (en) * | 2000-08-07 | 2002-02-14 | Centocor, Inc. | Anti-tnf antibodies, compositions, methods and uses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5888511A (en) * | 1993-02-26 | 1999-03-30 | Advanced Biotherapy Concepts, Inc. | Treatment of autoimmune diseases, including AIDS |
CA2385745C (en) * | 2001-06-08 | 2015-02-17 | Abbott Laboratories (Bermuda) Ltd. | Methods of administering anti-tnf.alpha. antibodies |
-
2007
- 2007-04-10 EP EP07755184A patent/EP2010213A4/en not_active Withdrawn
- 2007-04-10 WO PCT/US2007/008826 patent/WO2007120651A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002012502A2 (en) * | 2000-08-07 | 2002-02-14 | Centocor, Inc. | Anti-tnf antibodies, compositions, methods and uses |
Non-Patent Citations (10)
Title |
---|
BREEDVELD F C ET AL: "The efficacy and safety of Adalimunab (Humira((R))) plus Methotrexate vs. Adalimumab alone or methotrexate alone in the early treatment of rheumatoid arthritis (RA): 1-and 2-year results of the premier study", July 2005, ANNALS OF THE RHEUMATIC DISEASES, VOL. 64, NR. SUPPL. 3, PAGE(S) 60, ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY; VIENNA, AUSTRIA; JUNE 08 11, 2005, ISSN: 0003-4967, XP009132992 * |
CHIKANZA IAN C: "Juvenile rheumatoid arthritis: therapeutic perspectives.", PAEDIATRIC DRUGS 2002 LNKD- PUBMED:11994038, vol. 4, no. 5, 2002, pages 335 - 348, XP009132928, ISSN: 1174-5878 * |
HASHKES PHILIP J ET AL: "Medical treatment of juvenile idiopathic arthritis.", JAMA : THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 5 OCT 2005 LNKD- PUBMED:16204667, vol. 294, no. 13, 5 October 2005 (2005-10-05), pages 1671 - 1684, XP002580537, ISSN: 1538-3598 * |
HORNEFF G: "Treatment of juvenile idiopathic arthritis", ZEITSCHRIFT FÜR RHEUMATOLOGIE, STEINKOPFF-VERLAG, DA LNKD- DOI:10.1007/S00393-005-0748-Y, vol. 64, no. 5, 1 June 2005 (2005-06-01), pages 317 - 326, XP019382946, ISSN: 1435-1250 * |
LAHDENNE P ET AL: "Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: An open label study.", ANNALS OF THE RHEUMATIC DISEASES, vol. 62, no. 3, March 2003 (2003-03-01), pages 245 - 247, XP009132942, ISSN: 0003-4967 * |
LOVELL D: "Biologic agents for the treatment of juvenile rheumatoid arthritis: Current status", PEDIATRIC DRUGS 2004 NZ LNKD- DOI:10.2165/00148581-200406030-00001, vol. 6, no. 3, 2004, pages 137 - 146, XP009132929, ISSN: 1174-5878 * |
LOVELL DANIEL J ET AL: "Etanercept in children with polyarticular juvenile rheumatoid arthritis", NEW ENGLAND JOURNAL OF MEDICINE, vol. 342, no. 11, 16 March 2000 (2000-03-16), pages 763 - 769, XP002580532, ISSN: 0028-4793 * |
LOVELL DANIEL J ET AL: "Preliminary data from the study of adalimumab in children with Juvenile Idiopathic Arthritis", ARTHRITIS & RHEUMATISM, vol. 50, no. Suppl. S, 1096, 2004, & 68TH ANNUAL SCIENTIFIC MEETING OF THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY; SAN ANTONIO, TX, USA; OCTOBER 16 -21, 2004, pages S436 - S437, XP009132938, ISSN: 0004-3591 * |
MARTINI GIORGIA ET AL: "Juvenile idiopathic arthritis: current and future treatment options.", EXPERT OPINION ON PHARMACOTHERAPY MAR 2006 LNKD- PUBMED:16503811, vol. 7, no. 4, March 2006 (2006-03-01), pages 387 - 399, XP009132927, ISSN: 1744-7666 * |
WEISS J E ET AL: "Juvenile idiopathic arthritis", PEDIATRIC CLINICS OF NORTH AMERICA 200504 US LNKD- DOI:10.1016/J.PCL.2005.01.007, vol. 52, no. 2, April 2005 (2005-04-01), pages 413 - 442, XP009132933, ISSN: 0031-3955 * |
Also Published As
Publication number | Publication date |
---|---|
EP2010213A2 (en) | 2009-01-07 |
WO2007120651A2 (en) | 2007-10-25 |
WO2007120651A3 (en) | 2008-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2010214A4 (en) | Uses and compositions for treatment of rheumatoid arthritis | |
EP2010213A4 (en) | Uses and compositions for treatment of juvenile rheumatoid arthritis | |
EP2007426A4 (en) | Uses and compositions for treatment of psoriatic arthritis | |
EP2112880A4 (en) | Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment | |
HK1134679A1 (en) | Compositions and methods for the treatment of infections | |
PT2101766T (en) | Compositions and methods of using (r)-pramipexole | |
EP2104513A4 (en) | Ovr110 antibody compositions and methods of use | |
IL190520A0 (en) | Compositions and methods for treatment of autoimmune | |
EP2004666A4 (en) | Ras mutation and compositions and methods related thereto | |
EP2012803A4 (en) | Polymeric compositions and methods of making and using thereof | |
IL197945A (en) | Liquid chalcogenide compositions and methods of producing them | |
EP2182810A4 (en) | Compositions and methods for treatment and prevention of osteoarthritis | |
PL2069467T3 (en) | Separating compositions and methods of use | |
IL197528A0 (en) | Synthesis, methods of using, and compositions of cycloalkylmethylamines | |
PL1816116T6 (en) | Chemical compositions and methods of making them | |
PL2101766T3 (en) | Compositions and methods of using (r)-pramipexole | |
IL196843A0 (en) | Compositions and methods for the treatment of radiation proctosigmoitis | |
ZA201101932B (en) | Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment | |
EP2079755A4 (en) | Process for generation of protein and uses thereof | |
EP1996218A4 (en) | Methods and compositions for the treatment of gastrointestinal disorders | |
EP2104554A4 (en) | Compositions of particles | |
EP2254588A4 (en) | Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis | |
IL196411A0 (en) | Anti-cocaine compositions and treatment | |
EP1912630A4 (en) | Compositions and methods for the reduction of post-operative pain | |
GB0601950D0 (en) | Compositions and methods of treating diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20081110 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1126676 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100713 |
|
17Q | First examination report despatched |
Effective date: 20110609 |
|
RAX | Requested extension states of the european patent have changed |
Extension state: RS Payment date: 20081110 Extension state: HR Payment date: 20081110 Extension state: MK Payment date: 20081110 Extension state: BA Payment date: 20081110 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ABBVIE BIOTECHNOLOGY LTD |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20150422 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1126676 Country of ref document: HK |